Ian T. Clark sold Olema Pharmaceuticals ($OLMA) shares on the open market three times in the last year for a total of $7.9 million, with his most recent sale on December 19, 2025; these sales rank 1,366th among insiders. He also sold Guardant Health ($GH) shares four times for $3.4 million, most recently on December 5, 2025, ranking 2,502nd. Among nearly 12,000 insiders, the average is $8.6 million across about 6.4 transactions. Clark made no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 19, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | CLARK IAN T | Not found | M | Common Stock | 209690 | $4.41 | 209,690.0000 | 85,732,221 | 9999.99% | 0.24% |
| Dec. 19, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | CLARK IAN T | Not found | M | Stock Option (Right to Buy) | 12070 | $0.00 | 12,080.0000 | 85,732,221 | 49.98% | 0.01% |
| Dec. 19, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | CLARK IAN T | Not found | M | Stock Option (Right to Buy) | 21520 | $0.00 | 0.0000 | 85,732,221 | 100.00% | 0.03% |
| Dec. 19, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | CLARK IAN T | Not found | M | Stock Option (Right to Buy) | 21520 | $0.00 | 0.0000 | 85,732,221 | 100.00% | 0.03% |
| Dec. 19, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | CLARK IAN T | Not found | M | Stock Option (Right to Buy) | 209690 | $0.00 | 0.0000 | 85,732,221 | 100.00% | 0.24% |
| Dec. 19, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | CLARK IAN T | Not found | S | Common Stock | 41840 | $30.48 | 0.0000 | 85,732,221 | 100.00% | 0.05% |
| Dec. 19, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | CLARK IAN T | Not found | S | Common Stock | 193056 | $29.71 | 41,840.0000 | 85,732,221 | 82.19% | 0.23% |
| Dec. 19, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | CLARK IAN T | Not found | S | Common Stock | 29904 | $28.83 | 234,896.0000 | 85,732,221 | 11.29% | 0.03% |
| Dec. 19, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | CLARK IAN T | Not found | M | Common Stock | 12070 | $4.08 | 264,800.0000 | 85,732,221 | 4.78% | 0.01% |
| Dec. 19, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | CLARK IAN T | Not found | M | Common Stock | 21520 | $7.84 | 252,730.0000 | 85,732,221 | 9.31% | 0.03% |
| Dec. 19, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | CLARK IAN T | Not found | M | Common Stock | 21520 | $3.61 | 231,210.0000 | 85,732,221 | 10.26% | 0.03% |
| Dec. 5, 2025 | Guardant Health, Inc. | $GH | CLARK IAN T | Director | M | Common Stock | 8803 | $38.01 | 27,759.0000 | 126,041,089 | 46.44% | 0.01% |
| Dec. 5, 2025 | Guardant Health, Inc. | $GH | CLARK IAN T | Director | M | Stock Option (Right to Buy) | 10703 | $0.00 | 0.0000 | 126,041,089 | 100.00% | 0.01% |
| Dec. 5, 2025 | Guardant Health, Inc. | $GH | CLARK IAN T | Director | M | Stock Option (Right to Buy) | 8803 | $0.00 | 0.0000 | 126,041,089 | 100.00% | 0.01% |
| Dec. 5, 2025 | Guardant Health, Inc. | $GH | CLARK IAN T | Director | M | Stock Option (Right to Buy) | 9105 | $0.00 | 0.0000 | 126,041,089 | 100.00% | 0.01% |
| Dec. 5, 2025 | Guardant Health, Inc. | $GH | CLARK IAN T | Director | S | Common Stock | 3400 | $108.05 | 9,851.0000 | 126,041,089 | 25.66% | 0.00% |
| Dec. 5, 2025 | Guardant Health, Inc. | $GH | CLARK IAN T | Director | S | Common Stock | 17055 | $107.27 | 13,251.0000 | 126,041,089 | 56.28% | 0.01% |
| Dec. 5, 2025 | Guardant Health, Inc. | $GH | CLARK IAN T | Director | S | Common Stock | 8156 | $106.67 | 30,306.0000 | 126,041,089 | 21.21% | 0.01% |
| Dec. 5, 2025 | Guardant Health, Inc. | $GH | CLARK IAN T | Director | M | Common Stock | 10703 | $31.84 | 38,462.0000 | 126,041,089 | 38.56% | 0.01% |
| Dec. 5, 2025 | Guardant Health, Inc. | $GH | CLARK IAN T | Director | M | Common Stock | 9105 | $38.42 | 18,956.0000 | 126,041,089 | 92.43% | 0.01% |
| Aug. 1, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | CLARK IAN T | Director | A | Common Stock | 7000 | $0.00 | 7,000.0000 | 196,708,000 | 9999.99% | 0.00% |
| July 8, 2025 | GoodRx Holdings, Inc. | $GDRX | CLARK IAN T | Director | M | Class A Common Stock | 17248 | $4.74 | 100,150.0000 | 392,172,000 | 20.81% | 0.00% |
| July 8, 2025 | GoodRx Holdings, Inc. | $GDRX | CLARK IAN T | Director | M | Restricted Stock Unit | 17248 | $0.00 | 34,497.0000 | 392,172,000 | 33.33% | 0.00% |
| June 18, 2025 | Guardant Health, Inc. | $GH | CLARK IAN T | Director | A | Stock Option (Right to Buy) | 6833 | $0.00 | 6,833.0000 | 123,421,441 | 9999.99% | 0.01% |
| June 17, 2025 | Guardant Health, Inc. | $GH | CLARK IAN T | Director | S | Common Stock | 6672 | $48.38 | 9,851.0000 | 123,421,441 | 40.38% | 0.01% |
| June 18, 2025 | Guardant Health, Inc. | $GH | CLARK IAN T | Director | A | Restricted Stock Units | 5092 | $0.00 | 5,092.0000 | 123,421,441 | 9999.99% | 0.00% |
| June 12, 2025 | Corvus Pharmaceuticals, Inc. | $CRVS | CLARK IAN T | Not found | A | Stock Option (Right to Buy) | 15000 | $0.00 | 15,000.0000 | 75,152,514 | 9999.99% | 0.02% |
| June 12, 2025 | Guardant Health, Inc. | $GH | CLARK IAN T | Director | M | Common Stock | 8088 | $0.00 | 16,523.0000 | 123,421,441 | 95.89% | 0.01% |
| June 12, 2025 | Guardant Health, Inc. | $GH | CLARK IAN T | Director | M | Restricted Stock Units | 8088 | $0.00 | 0.0000 | 123,421,441 | 100.00% | 0.01% |
| June 11, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | CLARK IAN T | Not found | A | Stock Option (right to buy) | 24150 | $0.00 | 24,150.0000 | 58,743,522 | 9999.99% | 0.04% |
| June 3, 2025 | GoodRx Holdings, Inc. | $GDRX | CLARK IAN T | Director | A | Class A Common Stock | 57050 | $0.00 | 82,902.0000 | 392,172,000 | 220.68% | 0.01% |
| May 29, 2025 | Kyverna Therapeutics, Inc. | $KYTX | CLARK IAN T | Not found | A | Stock Option (right to buy) | 65351 | $0.00 | 65,351.0000 | 43,214,918 | 9999.99% | 0.15% |
| May 29, 2025 | Kyverna Therapeutics, Inc. | $KYTX | CLARK IAN T | Not found | A | Common Stock | 16634 | $0.00 | 16,634.0000 | 43,214,918 | 9999.99% | 0.04% |
| Nov. 12, 2024 | Guardant Health, Inc. | $GH | CLARK IAN T | Director | S | Common Stock | 7242 | $29.44 | 16,870.0000 | 0 | 30.03% | 0.00% |
| Nov. 12, 2024 | Guardant Health, Inc. | $GH | CLARK IAN T | Director | M | Stock Option (Right to Buy) | 1076 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 12, 2024 | Guardant Health, Inc. | $GH | CLARK IAN T | Director | J | Common Stock | 8435 | $0.00 | 8,435.0000 | 0 | 9999.99% | 0.00% |
| Nov. 12, 2024 | Guardant Health, Inc. | $GH | CLARK IAN T | Director | J | Common Stock | 8435 | $0.00 | 8,435.0000 | 0 | 50.00% | 0.00% |
| Nov. 12, 2024 | Guardant Health, Inc. | $GH | CLARK IAN T | Director | S | Common Stock | 1076 | $29.52 | 24,112.0000 | 0 | 4.27% | 0.00% |
| Nov. 12, 2024 | Guardant Health, Inc. | $GH | CLARK IAN T | Director | M | Common Stock | 1076 | $4.18 | 25,188.0000 | 0 | 4.46% | 0.00% |
| July 8, 2024 | GoodRx Holdings, Inc. | $GDRX | CLARK IAN T | Director | A | Restricted Stock Unit | 51745 | $0.00 | 51,745.0000 | 410,315,000 | 9999.99% | 0.01% |
| July 8, 2024 | GoodRx Holdings, Inc. | $GDRX | CLARK IAN T | Director | A | Class A Common Stock | 25852 | $0.00 | 25,852.0000 | 410,315,000 | 9999.99% | 0.01% |
| June 14, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | CLARK IAN T | Not found | A | Stock Option (right to buy) | 23000 | $0.00 | 23,000.0000 | 45,247,098 | 9999.99% | 0.05% |
| June 13, 2024 | Corvus Pharmaceuticals, Inc. | $CRVS | CLARK IAN T | Not found | A | Stock Option (Right to Buy) | 15000 | $0.00 | 15,000.0000 | 49,038,582 | 9999.99% | 0.03% |
| June 12, 2024 | Guardant Health, Inc. | $GH | CLARK IAN T | Director | A | Restricted Stock Units | 8088 | $0.00 | 8,088.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2024 | Guardant Health, Inc. | $GH | CLARK IAN T | Director | M | Common Stock | 6776 | $0.00 | 15,677.0000 | 0 | 76.13% | 0.00% |
| June 12, 2024 | Guardant Health, Inc. | $GH | CLARK IAN T | Director | M | Restricted Stock Units | 6776 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 12, 2024 | Guardant Health, Inc. | $GH | CLARK IAN T | Director | A | Stock Option (Right to Buy) | 10703 | $0.00 | 10,703.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | CLARK IAN T | Not found | A | Stock Option (right to buy) | 21520 | $0.00 | 21,520.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2023 | Tectonic Therapeutic, Inc. | $TECX | CLARK IAN T | Director | A | Stock Option (Right to Buy) | 17643 | $0.00 | 17,643.0000 | 0 | 9999.99% | 0.00% |